Temporal effect of HLA-B*57 on viral control during primary HIV-1 infection

Retrovirology

Volumn 10, Issue 1, 2013, Pages

  Vaidya, Sagar A ^a   Streeck, Hendrik ^a,b,c   Beckwith, Noor ^a   Ghebremichael, Musie ^a   Pereyra, Florencia ^a   Kwon, Douglas S ^a   Addo, Marylyn M ^a,d   Rychert, Jenna ^a   Routy, Jean Pierre ^e   Jessen, Heiko ^f   Kelleher, Anthony D ^g   Hecht, Frederick ^h   Sekaly, Rafick Pierre ⁱ   Carrington, Mary ^j   Walker, Bruce D ^a,k   Allen, Todd M ^a   Rosenberg, Eric S ^a   Altfeld, Marcus ^a,l  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^c HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^e MCGILL UNIVERSITY   (Canada)

^f HIV Clinic Praxis Jessen   (Germany)

^g UNIVERSITY OF NEW SOUTH WALES   (Australia)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^j FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

^k HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^l LEIBNIZ INSTITUTE FOR EXPERIMENTAL VIROLOGY   (Germany)

more..

Author keywords

Acute HIV 1 infection; HLA B; HLA B*57; MHC class I; Primary HIV 1 infection; Viral load set point

Indexed keywords

HLA ANTIGEN CLASS 1; HLA B27 ANTIGEN; HLA B57 ANTIGEN;

ALLELE; AMINO ACID SEQUENCE; ANTIGEN FUNCTION; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; GENE FUNCTION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HEREDITY; HLA TYPING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE RESPONSE; INFECTION PREVENTION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MICROBIOLOGICAL PARAMETERS; MOLECULAR MECHANICS; PRIMARY INFECTION; RETROSPECTIVE STUDY; VIRAL LOAD SET POINT; VIRUS INHIBITION; VIRUS LOAD; VIRUS REPLICATION;

ADULT; AMINO ACID SUBSTITUTION; FEMALE; HIV INFECTIONS; HIV-1; HLA-B ANTIGENS; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; POINT MUTATION; POLYMORPHISM, GENETIC; TIME FACTORS; VIRAL LOAD;

EID: 84888346475     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-10-139     Document Type: Article

References (14)

1. Kiepiela P, et al. Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. Nature 2004, 432(7018):769-75. 10.1038/nature03113, 15592417.
2. Carrington M, Walker BD. Immunogenetics of spontaneous control of HIV. Annu Rev Med 2012, 63:131-45. 10.1146/annurev-med-062909-130018, 3725592, 22248321.
3. Costello C, et al. HLA-B*5703 independently associated with slower HIV-1 disease progression in Rwandan women. AIDS 1999, 13(14):1990-1. 10.1097/00002030-199910010-00031, 10513667.
4. Fellay J, et al. A whole-genome association study of major determinants for host control of HIV-1. Science 2007, 317(5840):944-7. 10.1126/science.1143767, 1991296, 17641165.
5. Kelleher AD, et al. Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses. J Exp Med 2001, 193(3):375-86. 10.1084/jem.193.3.375, 2195921, 11157057.
6. Pereyra F, et al. The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science 2010, 330(6010):1551-7. 3235490, 21051598.
7. Carrington M, et al. HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science 1999, 283(5408):1748-52. 10.1126/science.283.5408.1748, 10073943.
8. Kelley CF, Barbour JD, Hecht FM. The relation between symptoms, viral load, and viral load set point in primary HIV infection. J Acquir Immune Defic Syndr 2007, 45(4):445-8. 10.1097/QAI.0b013e318074ef6e, 17514014.
9. Gao X, et al. AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis. Nat Med 2005, 11(12):1290-2. 10.1038/nm1333, 16288280.
10. Kaslow RA, et al. Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat Med 1996, 2(4):405-11. 10.1038/nm0496-405, 8597949.
11. Altfeld M, et al. Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection. AIDS 2003, 17(18):2581-91. 10.1097/00002030-200312050-00005, 14685052.
12. Gillespie GM, et al. Strong TCR conservation and altered T cell cross-reactivity characterize a B*57-restricted immune response in HIV-1 infection. J Immunol 2006, 177(6):3893-902.
13. Alter G, et al. HIV-1 adaptation to NK-cell-mediated immune pressure. Nature 2011, 476(7358):96-100. 10.1038/nature10237, 3194000, 21814282.
14. Stewart-Jones GB, et al. Structures of three HIV-1 HLA-B*5703-peptide complexes and identification of related HLAs potentially associated with long-term nonprogression. J Immunol 2005, 175(4):2459-68.